Throughout his career, Ramin Valian, Vice President of International Glaucoma, Reimbursement Pipeline, for Allergan, has stayed by the side of his mentors.

Fresh out of college, where he earned degrees in Middle Eastern studies and Russian, he shifted his goals from working at the U.S. Department of State to joining his older sister at Roche. After learning the pharmaceutical industry ropes as a sales representative, he followed his supervisor, industry leader Joseph Schultz, to Johnson & Johnson and then Allergan.

Holding various leadership roles over the past 15-plus years, Ramin has helped launch every one of Allergan’s glaucoma products. With host Ehsan Sadri, MD, Ramin discusses his tenure at Allergan, the acquisition by AbbVie, and his ability to adapt to change.

When you listen to this podcast, you’ll also hear Ramin’s take on:

• The new frontier for presbyopia: the latest on AGN-190584, AbbVie/Allergan’s drop.
• The AbbVie/Allergan innovation pipeline, including a collaboration with REGENXBIO for gene therapy in the retina space.
• The four pieces of advice he gives to entrepreneurs and mentees.
• How he’s navigated a long career through mergers, buyouts, and other external pressures.